$CNS Pharmaceuticals(CNSP)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-007108 Size: 8 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-007110 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-007111 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-006682 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-006684 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-006686 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-006676 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-006680 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-006678 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001683168-23-006528 Act: 34 Size: 334 KB 网页链接